CD274 and head and neck squamous cell carcinoma: A PD‐L1 expression of TC ≥ 1% was reported in 19 (45.2%), 25 (59.5%), and 19 (59.4%) patients with BTC, ESCC, and HNSCC, respectively (Table 1).